Top Stories

AbbVie and FutureGen announce license agreement to develop next-generation therapy for inflammatory bowel disease 

AbbVie and FutureGen Biopharmaceutical have announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development, whilst utilising FutureGen’s Structure-based Targeted...

Galaxy AI is coming to new Galaxy watch for more motivational health 

Earlier this year, Samsung established the era of mobile AI with the launch of the Galaxy S24 series, and committed to introducing Galaxy AI on a wider range of devices. True to this promise, Samsung is now bringing Galaxy AI to Galaxy Watch, enhancing its...

Fast-growing mental health solution partners with Headspace 

Uwill, the nation’s fastest-growing mental health and wellness solution that serves more than 2 million students at 300 colleges in 50 states and 40 countries, has announced an exclusive partnership to offer Headspace, the world’s most...

Microsoft announces expansion of trustworthy AI Network to Europe

At the HLTH Europe conference, the Trustworthy and Responsible AI Network (TRAIN), a consortium of healthcare leaders, announced its expansion to Europe with the objective to help organisations in the region operationalize responsible AI through...

Bank Midwest’s OnePlace.bank goes live with Finastra to deliver tailored financial services to the healthcare sector 

Finastra has announced that Bank Midwest, an employee-owned bank with locations throughout Iowa, Minnesota and South Dakota, has launched OnePlace.bank, a digital bank powered by Finastra, focused exclusively on the financial needs of the healthcare...

Tempus expands collaboration with AstraZeneca to support guideline-directed biomarker testing in NSCLC 

Tempus, a leader in Artificial Intelligence and precision medicine, has announced an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker...

The intersection of telemedicine decline and rising NEMT demand has implications for outpatient care and healthcare systems 

Telemedicine’s 15 minutes of fame appear to be fizzling, a trend that could compound the already staggering financial losses — a whopping US$150 billion annually — for the healthcare industry due to patient no-shows. One of the most common reasons given for no-sh...

Harmonising the power of AI with the future we want to build

César Cernuda, Global President of NetApp, delves into the transformative potential of AI, its critical dependence on data and the ethical considerations we must navigate. Today, Artificial Intelligence is perceived as a revolutionary force that will change ...

Ocutrx Technologies sets new standards in Augmented and Mixed Reality healthcare with over 25 patents  

In a significant stride for Augmented Reality (AR) and 3D technology, Ocutrx Technologies has announced the allowance of its 26th patent, marking a monumental achievement in the company’s journey towards pioneering innovation in healthcare, enterprise...

Dhiti Omics now live on SOPHiA DDM

Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA DDM Platform. The company will use SOPHiA GENETICS’ technology to enhance its solid tumor testing capabilities. SOPHiA GENETICS is a...

A3Data creates ‘virtual clinic’ for employees and generates an 11% reduction in claims for companies

Named ‘Maria Saúde’, the platform offers primary health care services with the support of AI supervised by a multidisciplinary team. Application is aimed at companies that offer health insurance to employees. A3Data, a data and AI consultancy, ...

How can we utilise technology to enhance preventive healthcare and what incentives could drive behavioural changes among potential future patients? 

While at HLTH Europe, there was a notable focus on preventative healthcare, accompanied by tense remarks about the profitability of preventive technologies versus treatments for existing illnesses. Another aspect of this discussion highlighted the challenge...